In human laryngeal carcinoma HEp2 cells, the expression of IFI44L is upregulated and can ultimately suppress the progression of laryngeal carcinoma by triggering apoptosis of laryngeal carcinoma cells through interaction with IFN-α (6). This evidence concerns the gene IFI44L and laryngeal carcinoma.